Giant Cell Arteritis

Impact of the COVID-19 lockdown on the management and control of patients with GCA
Roman Praliaud, Helene Greigert, Maxime Samson, Marianne Zeller, Mathieu Boulin, Philip Bielefeld, André Ramon, Yves Cottin, Bernard Bonnotte

Annals of the Rheumatic Diseases Aug 2020, annrheumdis-2020-218360; DOI: 10.1136/annrheumdis-2020-218360
Increased rather than decreased incidence of giant-cell arteritis during the COVID-19 pandemic
Augustin Lecler, Delphine Villeneuve, Catherine Vignal, Thomas Sené

Annals of the Rheumatic Diseases Aug 2020, annrheumdis-2020-218343; DOI: 10.1136/annrheumdis-2020-218343
Elucidation of disease mechanisms underlying rheumatic immune-related adverse events may lead to novel therapeutic strategies for autoimmune diseases
Ryu Watanabe, Motomu Hashimoto

Annals of the Rheumatic Diseases Aug 2020, annrheumdis-2020-217995; DOI: 10.1136/annrheumdis-2020-217995
Response to: ‘Diagnostic value of ultrasound halo count and Halo Score in giant cell arteritis: a retrospective study from routine care’ by Molina Collada et al
Kornelis SM van der Geest, Bhaskar Dasgupta

Annals of the Rheumatic Diseases Aug 2020, annrheumdis-2020-218654; DOI: 10.1136/annrheumdis-2020-218654
Diagnostic value of ultrasound halo count and Halo Score in giant cell arteritis: a retrospective study from routine care
Juan Molina Collada, Julia Martínez-Barrio, Belén Serrano-Benavente, Isabel Castrejón, Liz Rocío Caballero Motta, Laura Trives Folguera, José María Álvaro-Gracia

Annals of the Rheumatic Diseases Aug 2020, annrheumdis-2020-218631; DOI: 10.1136/annrheumdis-2020-218631
Successful remission with tofacitinib in a patient with refractory Takayasu arteritis complicated by ulcerative colitis
Saki Kuwabara, Shun Tanimura, Shogo Matsumoto, Hiroyuki Nakamura, Tetsuya Horita

Annals of the Rheumatic Diseases Aug 2020, 79 (8) 1125-1126; DOI: 10.1136/annrheumdis-2019-216606
Analysis of IL-6 measurement in patients with GCA treated with tocilizumab should consider concomitant treatment with prednisone
Maxime Samson, Bernard Bonnotte

Annals of the Rheumatic Diseases Aug 2020, 79 (8) e102; DOI: 10.1136/annrheumdis-2019-215697
Longitudinal versus cross-sectional IL-6 measurements in tocilizumab-treated GCA. Response to: ‘Analysis of IL-6 measurement in GCA patients treated with tocilizumab should consider concomitant treatment with prednisone’ by Samson and Bonnotte
Christoph T Berger, Thomas Daikeler

Annals of the Rheumatic Diseases Aug 2020, 79 (8) e103; DOI: 10.1136/annrheumdis-2019-215729
‘Halo Score’: missing large-vessel giant cell arteritis— do we need a ‘modified Halo Score’?
Arghya Chattopadhyay, Alakendu Ghosh

Annals of the Rheumatic Diseases Jul 2020, annrheumdis-2020-218224; DOI: 10.1136/annrheumdis-2020-218224
Response to: ‘‘Halo Score’: missing large vessel giant cell arteritis– do we need a modified ‘Halo Score?’’ by Chattopadhyay and Ghosh
Kornelis S M van der Geest, Bhaskar Dasgupta

Annals of the Rheumatic Diseases Jul 2020, annrheumdis-2020-218262; DOI: 10.1136/annrheumdis-2020-218262

Main menu

Giant Cell Arteritis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Giant Cell Arteritis

Pages